Bernried, Germany

Rolf Deeg


Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 193(Granted Patents)


Location History:

  • Seeshaupt, DE (1984 - 1989)
  • Bernried, DE (1987 - 2003)

Company Filing History:


Years Active: 1984-2003

Loading Chart...
15 patents (USPTO):

Title: The Innovative Mind of Rolf Deeg

Introduction

Rolf Deeg, a prolific inventor based in Bernried, Germany, stands out in the field of biotechnology with an impressive portfolio of 15 patents. His innovative contributions to the realm of immunological detection and therapeutic solutions have garnered significant attention, establishing him as a notable figure in the industry.

Latest Patents

One of Deeg's latest patents focuses on monoclonal antibodies against a complex of human ACT (alpha-1-antichymotrypsin) and a serine protease. This invention is particularly groundbreaking as it concerns antibodies that exhibit minimal cross-reactivity with free, non-complexed human ACT and PSA (prostate-specific antigen). This specificity allows for improved diagnostic test methods aimed at detecting serine protease-ACT complexes, notably PSA-ACT, using these monoclonal antibodies.

Another significant patent involves a novel process for determining an immunologically detectable substance through a heterogeneous immunoassay. This method utilizes a reaction vessel with a solid phase, which features an inner surface bound with either streptavidin or avidin. By optimizing the concentration of these components, the invention addresses the need for accurate and sensitive measurements of immunologically active substances in diagnostics.

Career Highlights

Rolf Deeg has made notable contributions throughout his career, working with esteemed companies such as Boehringer Mannheim GmbH and Roche Diagnostics GmbH. His work in these organizations has been instrumental in advancing medical diagnostics and therapeutics, demonstrating his commitment to innovation in the biomedical field.

Collaborations

Throughout his career, Deeg has collaborated with esteemed professionals like Joachim Ziegenhorn and Eberhard Maurer. These partnerships have enabled the sharing of knowledge and expertise, fostering innovations that have had a lasting impact on the industry.

Conclusion

Rolf Deeg's contributions to science and technology through his patents and collaborative efforts illustrate the power of innovation in the healthcare sector. His work not only enhances diagnostic capabilities but also holds promise for new therapeutic approaches, showcasing the critical role inventors play in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…